Table 2.
Group | Serum |
Liver |
|||||
---|---|---|---|---|---|---|---|
GSH (µmol/g prot) | GSSG (µmol/g prot) | GSH/GSSG | GSH (µmol/g prot) | GSSG (µmol/g prot) | GSH/GSSG | ||
Control | 45.62 ± 10.81 | 3.87 ± 0.91 | 12.27 ± 3.01 | 1.19 ± 0.23 | 1.91 ± 0.21 | 0.86 ± 0.19 | |
0.5%Q | 8.12 ± 3.23* | 3.55 ± 0.68 | 1.75 ± 0.68* | 0.61 ± 0.28* | 1.71 ± 0.14* | 0.47 ± 0.21* |
Values are presented as mean ± standard deviation (n = 10). *p<0.05, compared with control. Serum GSH and GSH/GSSG, and hepatic GSH, GSSG and GSH/GSSG all decreased significantly, and and p value were 0.000, 0.000, 0.000, 0.023 and 0.000 respectively. GSH, glutathione; 0.5%Q, 0.5% quercetin-supplemented group.